Stockscreener 앱 받기
2.88
1.41%
0.04
시간 외 거래:
2.89
0.01
+0.35%
전일 마감가:
$2.84
열려 있는:
$2.83
하루 거래량:
1.10M
Relative Volume:
1.44
시가총액:
$215.42M
수익:
$405.47M
순이익/손실:
$53.66M
주가수익비율:
4.00
EPS:
0.72
순현금흐름:
$131.28M
1주 성능:
+14.29%
1개월 성능:
-5.88%
6개월 성능:
-24.21%
1년 성능:
-38.72%
1일 변동 폭
$2.795
$3.005
1주일 범위
$2.54
$3.005
52주 변동 폭
$2.36
$4.98
Orasure Technologies Inc Stock (OSUR) Company Profile
명칭
Orasure Technologies Inc
전화
(503) 641-6115
주소
220 E FIRST ST, BETHLEHEM, PA
OSUR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
2.88 | 188.50M | 405.47M | 53.66M | 131.28M | 0.72 |
|
ISRG
Intuitive Surgical Inc
|
552.34 | 193.38B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
172.59 | 49.12B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
85.94 | 42.79B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
244.79 | 35.61B | 5.02B | 1.31B | 1.56B | 8.91 |
|
BAX
Baxter International Inc
|
30.50 | 15.46B | 11.89B | -560.00M | 191.00M | -1.10 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-01-03 | 재개 | Evercore ISI | In-line |
| 2021-09-22 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-08-21 | 개시 | Evercore ISI | Outperform |
| 2020-08-10 | 개시 | Citigroup | Buy |
| 2020-08-10 | 개시 | JP Morgan | Neutral |
| 2020-08-07 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-06-25 | 개시 | Lake Street | Buy |
| 2020-04-21 | 재개 | Stephens | Equal-Weight |
| 2018-10-23 | 재개 | Raymond James | Mkt Perform |
| 2018-07-16 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2017-11-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2017-02-09 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2016-06-13 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-11-05 | 재확인 | Mizuho | Buy |
| 2015-05-07 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-01-23 | 재확인 | Mizuho | Buy |
| 2014-06-12 | 재확인 | Canaccord Genuity | Buy |
| 2014-06-11 | 재확인 | Mizuho | Buy |
| 2012-12-21 | 개시 | Mizuho | Buy |
| 2012-08-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2012-07-05 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2012-03-27 | 개시 | JMP Securities | Mkt Outperform |
모두보기
Orasure Technologies Inc 주식(OSUR)의 최신 뉴스
Top Penny Stocks To Watch In May 2025 - simplywall.st
OraSure Technologies: Multiple Shots To Deliver Value (NASDAQ:OSUR) - Seeking Alpha
Orasure Technologies Inc Files For Mixed Shelf Of Up To $300 MillionSEC Filing - marketscreener.com
OraSure (OSUR) Files for $300 Million Mixed Securities Offering - GuruFocus
Evercore says 23andMe buyout removes downside case for OraSure - Yahoo Finance
OraSure Technologies (NASDAQ:OSUR) Receives “In-Line” Rating from Evercore ISI - Defense World
Jane Street Group LLC Has $1.47 Million Stock Position in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure rises as seen benefitting from 23andMe/Regeneron deal - MSN
OraSure Technologies (OSUR) Rises on Regeneron-23andMe Deal - GuruFocus
OraSure stock rises following Regeneron’s 23andMe acquisition - Investing.com
OraSure Technologies (OSUR) Maintains In-Line Rating with Everco - GuruFocus
Hold Rating on Orasure Technologies Amid 23andMe Acquisition and Revenue Uncertainties - TipRanks
OraSure (OSUR) Sees Positive Outlook with 23andMe Partnership | - GuruFocus
OraSure Technologies (OSUR) Sees Positive Market Reaction | OSUR Stock News - GuruFocus
OraSure (OSUR) Sees Positive Outlook with 23andMe Partnership | OSUR Stock News - GuruFocus
OraSure’s Board of Directors has a new Member Stephen S. Tang, Ph.D., has joined OraSure T - Medical Product Outsourcing
OraSure Technologies (NASDAQ:OSUR) Raised to Hold at StockNews.com - Defense World
Tower Research Capital LLC TRC Grows Position in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Targeted Genomics, OraSure in pact for at-home celiac genetic testing - MSN
10,227 Shares in OraSure Technologies, Inc. (NASDAQ:OSUR) Bought by Raymond James Financial Inc. - Defense World
Voya Investment Management LLC Sells 28,998 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure Technologies Approves Stock Plan Amendment at Annual Meeting - TipRanks
OraSure, Targeted Genomics in pact for at-home celiac genetic testing - Seeking Alpha
OraSure Technologies (OSUR) Partners to Enhance At-Home Celiac T - GuruFocus
Targeted Genomics Announces Commercial Collaboration with - GlobeNewswire
Targeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer (DTC) Celiac Genetic Testing - The Manila Times
OraSure Technologies (NASDAQ:OSUR) Cut to Sell at StockNews.com - Defense World
Orasure technologies outlines Q2 2025 revenue guidance of $28.5M-$32.5M amid new product launches and customer expansions - MSN
OraSure Executive Resigns, Effective June 30 - Investing.com
OraSure Executive Resigns, Effective June 30 By Investing.com - Investing.com India
OraSure Technologies First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
OraSure Technologies, Inc. (NASDAQ:OSUR) Q1 2025 Earnings Call Transcript - Insider Monkey
OraSure Technologies Announces CPO Resignation - TipRanks
Orasure Technologies, Inc. Announces Resignation of Chief Product Officer Kathleen G. Weber Effective June 30, 2025 - marketscreener.com
OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Sold by Envestnet Asset Management Inc. - Defense World
Evercore ISI cuts OraSure stock price target to $3 from $4 - Investing.com Nigeria
Shareholders Will Probably Hold Off On Increasing OraSure Technologies, Inc.'s (NASDAQ:OSUR) CEO Compensation For The Time Being - simplywall.st
Earnings call transcript: OraSure’s Q1 2025 beats EPS forecast, stock stable - Investing.com Nigeria
OraSure Technologies Inc (OSUR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
OraSure Technologies Inc (OSUR) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth - GuruFocus
OraSure Technologies Reports Q1 2025 Financial Results - TipRanks
OraSure: Q1 Earnings Snapshot - The Washington Post
OraSure reports first quarter loss, but looks forward to emerging as 'stronger enterprise' - WFMZ.com
OraSure Technologies (OSUR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
OraSure (OSUR) Reports Q1 Revenue Slightly Above Expectations | OSUR Stock News - GuruFocus
OraSure Technologies (OSUR) Projects Q2 2025 Revenue Growth | OS - GuruFocus
OraSure Technologies Reports Q1 2025 Revenue Decline - TipRanks
OraSure Technologies (OSUR) Projects Q2 2025 Revenue Growth | OSUR Stock News - GuruFocus
Orasure Technologies Inc (OSUR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Orasure Technologies Inc 주식 (OSUR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| EGLINTON MANNER CARRIE | President & CEO |
Feb 28 '25 |
Buy |
3.49 |
28,670 |
100,027 |
1,288,334 |
| EGLINTON MANNER CARRIE | President & CEO |
Feb 27 '25 |
Buy |
3.15 |
78,625 |
247,378 |
1,259,664 |
| Kenny John P. | Director |
Feb 27 '25 |
Buy |
3.17 |
47,659 |
151,217 |
70,915 |
| McGrath Kenneth J | Chief Financial Officer |
Feb 27 '25 |
Buy |
3.15 |
64,000 |
201,683 |
371,013 |
| Marmora Lelio | Director |
Feb 27 '25 |
Buy |
3.06 |
7,000 |
21,420 |
67,720 |
0.66%
1.15%
자본화:
|
볼륨(24시간):